Venmax Drugs & Pharmaceuticals Ltd Share Price

Venmax Drugs
Small Cap | Pharmaceuticals
₹ 23.08 1.09 (4.96%)
Last updated: 15-Oct-2025 , 16:01:52

Venmax Drugs & Pharmaceuticals Ltd Live Price Chart

Low: ₹23.08 High: 23.08
Open Your Trading & Demat Account
+91

Venmax Drugs & Pharmaceuticals Ltd Technicals

Current Price
₹ 23.08 1.09 (4.96%)
EMASMA
20 Day ₹ 22.815
50 Day ₹ 24.839
100 Day ₹ 25.255
200 Day ₹ 22.946
20 Day ₹ 22.995
50 Day ₹ 26.219
100 Day ₹ 26.065
200 Day ₹ 25.595

Venmax Drugs & Pharmaceuticals Ltd Performance

Previous Close ₹ 21.99
High ₹ 23.08
Volume 1
52W Range ₹ 6.27 - ₹ 36.96
Open ₹ 23.08
Low ₹ 23.08
Market Cap 11.52 Cr

Venmax Drugs & Pharmaceuticals Ltd Fundamentals

ROCE 0.302
P/E Ratio 769.330
P/B Ratio 2.750
Industry P/E 2.750
Debt to Equity 39.893
ROE 0.365
EPS 0.030
Dividend Yield 0.000
Book Value 8.378
Face Value 10.000

Venmax Drugs & Pharmaceuticals Ltd Financials

Particulars Y202503 Y202403 Y202303 Y202203 Y202103
Total Revenue 1.8605 0.1986 0.4193 1.983 0.3493107
Total Expenses 1.8746 0.1117 0.1936 0.1364 0.511109
Profit After Tax -0.0105 0.0645 0.2256 1.8463 -0.1624628

Venmax Drugs & Pharmaceuticals Ltd Shareholding Pattern

Promoter Holdings 23.135 %
FIIs 0.000 %
DIIs 0.000 %
MutualFund 0.000 %
Retail 65.006 %
Others - 11.859 %

About Venmax Drugs & Pharmaceuticals Ltd

History of Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Limited Company under the name and style of 'Yenkay Medico Private Limited', on 28 September, 1998. The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995. It became a Public Limited Company on February 3, 1995 with 'Yenkey Drugs & Pharmaceuticals Limited'. Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs). Initially, the Company engaged in the business of pharmaceutical product ...

Similar Stocks

Company 52 Week Market Price P/E Ratio
Gujarat Themis Biosyn Ltd ₹ 208 - ₹ 435 430 105.13
Jubilant Pharmova Ltd ₹ 802 - ₹ 1309.9 1060.4 486.47
Anuh Pharma Ltd ₹ 74.25 - ₹ 122.85 78.83 17.14
Aarti Drugs Ltd ₹ 312 - ₹ 564.05 507.5 26.12
Aarey Drugs & Pharmaceuticals Ltd ₹ 31.35 - ₹ 86.85 83.94 57.1

FAQs on Venmax Drugs & Pharmaceuticals Ltd

1. Can I buy Venmax Drugs & Pharmaceuticals Ltd from PL Capital? ›

Yes, you can invest in Venmax Drugs & Pharmaceuticals Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Venmax Drugs & Pharmaceuticals Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Venmax Drugs & Pharmaceuticals Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Venmax Drugs & Pharmaceuticals Ltd pay dividends? ›

Venmax Drugs & Pharmaceuticals Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.

3. What is the current share price of Venmax Drugs & Pharmaceuticals Ltd ? ›

As of 15-10-2025 the share price for Venmax Drugs & Pharmaceuticals Ltd. is 23.08 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Venmax Drugs & Pharmaceuticals Ltd ? ›

The 52-week high and low of Venmax Drugs & Pharmaceuticals Ltd share price is ₹ 6.27 - ₹ 36.96 as of 15-10-2025 .
PL Ringside View

Our fireside chat series where industry experts and top management share valuable insights for our clients

Youtube

Mark Mobius on India’s Growth, Global Markets, and Investment Opportunities

Youtube

₹100 cr net profit in 7-12 months | Anjali Nashier, Revolt Motors

Youtube

India's Path to Energy Security | Dr. Praveer Sinha, MD & CEO, Tata Power

  • PL Capital Logo

  • Regd. Office : 3rd Floor, Sadhana House,
    570, P. B. Marg, Behind Mahindra Tower,
    Worli, Mumbai - 400 018, India

    View on Google Maps

  • Tel. : 02266322222

    Call us

Prabhudas Lilladher Private Limited | CIN: U67190MH1983PTC029670 | Registered Office Address: 3rd Floor, Sadhana House, 570, P.B. Marg, Worli, Mumbai – 400018, Maharashtra, India | SEBI Registration Details: Stock Broking: INZ000196637 [Membership Codes: NSE – 05977; BSE – 564; MCX – 40690] | Depository Participant: IN-DP-439-2019 [DP Codes: CDSL – 12011300; NSDL – IN303868 | Portfolio Management: INP000009001| Research Analyst: INZ000000271 | Investment Advisors: INA000018267 [BSEASL Membership Code: BASL2042] | AMFI ARN: 3276 | Compliance Officer: Mrs. Snehal Kathrani; Tel: 02266322420; email: co@plindia.com | For any Grievance/ Dispute: Stock Broking; email: grievance-br@plindia.com; Tel: 02266322366; Depository Participant; email: grievance-dp@plindia.com; Tel: 02266322452; Portfolio Management; email: grievance-pms@plindia.com; Tel: 02266322350.

To register your grievance on SCORES log onto: https://scores.gov.in/scores/Welcome.html. Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID

To register your grievance on Smart ODR Portal log onto: Online Dispute Resolution Portal (ODR Portal).

Standard Disclaimers: (a) Investment in securities market are subject to market risks, read all the related documents carefully before investing. (b) Brokerage will not exceed the SEBI prescribed limits. (c) Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The brand name and Logo ‘PL Capital’ are the registered trademarks of Prabhudas Lilladher Advisory Services Private Limited which is the holding company of Prabhudas Lilladher Group of Companies .

Prabhudas Lilladher Private Limited is not associated with any unregulated platform which claims performance/return for algorithmic strategy for trading. Trading with unregulated platforms for algorithmic strategy shall be at your own risk and Prabhudas Lilladher Private Limited or its affiliates shall not be liable for the same.

Risk Disclosure on Derivatives: (a) 9 out of 10 individual traders in equity futures and options segment, incurred net losses. (b) On an average, loss makers registered net trading loss close to ₹ 50,000 (c) Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs. (d) Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source